Altimmune Inc. (ALT)
NASDAQ: ALT
· Real-Time Price · USD
3.54
0.01 (0.28%)
At close: Aug 22, 2025, 3:59 PM
3.53
-0.28%
After-hours: Aug 22, 2025, 07:53 PM EDT
0.28% (1D)
| Bid | 3.53 |
| Market Cap | 312.43M |
| Revenue (ttm) | 20K |
| Net Income (ttm) | -87.75M |
| EPS (ttm) | -1.18 |
| PE Ratio (ttm) | -3 |
| Forward PE | -2.58 |
| Analyst | Buy |
| Ask | 3.6 |
| Volume | 2,784,853 |
| Avg. Volume (20D) | 5,840,683 |
| Open | 3.51 |
| Previous Close | 3.53 |
| Day's Range | 3.51 - 3.65 |
| 52-Week Range | 2.90 - 11.16 |
| Beta | -0.01 |
Analyst Forecast
According to 0 analyst ratings, the average rating for ALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Altimmune has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Altimmune Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-53.18%
Altimmune shares are trading lower after the compa...
Unlock content with
Pro Subscription
5 months ago
+13.85%
Altimmune shares are trading higher amid rumours several large pharmaceutical organizations are interested in the company.
